Page 37 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 14 ฉบับที่ 3
P. 37

255




                 antinociceptive and weak rewarding effects in mice.  V, Tan S, Mansor S. Understanding the physicochemical
                 Neuropharmacology. 2008;55(2):154-65.       properties of mitragynine: a principal alkaloid of Mitragyna
              32. Kumarnsit E, Vongvatcharanon U, Kaewpradub N, Intasaro  speciosa for preclinical evaluation. Molecules. 2015;
                 P. Fos-like immunoreactivity in rat dorsal raphe nuclei  20(3):4915-27.
                 induced by alkaloid extract of Mitragyna speciosa. Neurosci  44. Manda VK, Avula B, Ali Z, Khan IA, Walker LA, Khan SI.
                 Lett. 2007;416(2):128-32.                   Evaluation of in vitro absorption, distribution, metabolism,
              33. Hassan Z, Muzaimi M, Navaratnam V, Yusoff NH, Suhaimi  and excretion (ADME) properties of mitragynine, 7-
                 FW, Vadivelu R, et al. From Kratom to mitragynine and its  hydroxymitragynine, and mitraphylline. Planta Med.
                 derivatives: Physiological and behavioural effects related  2014;80(7):568-76.
                 to use, abuse, and addiction. Neurosci Biobehav Rev.  45. Azizi J, Ismail S, Mansor SM. Mitragyna speciosa Korth
                 2013;37(2):138-51.                          leaves extracts induced the CYP450 catalyzed aminopyrine-
              34. Chittrakorn S, Kaewpradub N, Sawangiaroen K, Kansenalak  N-demethylase (APND) and UDP-glucuronosyl transferase
                 S, Janchawee B. The neuromuscular blockade produced  (UGT) activities in male Sprague-Dawley rat livers. Drug
                 by pure alkaloid, mitragynine and methanol extract of  Metabol Drug Interact. 2013;28(2):95-105.
                 kratom leaves (Mitragyna speciosa Korth.). J  46. Hanapi NA, Ismail S, Mansor SM. Inhibitory effect of
                 Ethnopharmacol. 2010;129(3):344-9.          mitragynine on human cytochrome P450 enzyme activities.
              35. Ghazali AR, Abdullah R, Ramli N, Rajab NF, Ahmad-Kamal  Pharmacognosy Res. 2013;5(4):241-6.
                 MS, Yahya NA. Mutagenic and antimutagenic activities of  47. ACT 366, POISONS ACT 1952 (REVISED - 1989).
                 Mitragyna speciosa Korth extract using ames test. J. Med.  Incorporating latest amendment - P.U.(A) 52/2009. (13
                 Plant. Res. 2011;5(8):1345-8.               April 1989).
              36. Azizi J, Ismail S, Mordi MN, Ramanathan S, Said MI,  48. §≥–°√√¡°“√ªØ‘√Ÿª°ÆÀ¡“¬. ∫—π∑÷°§«“¡‡ÀÁπ·≈–¢âÕ
                 Mansor SM. In vitro and in vivo effects of three different  ‡ πÕ·π–‡√◊ËÕß°ÆÀ¡“¬‡°’ˬ«°—∫æ◊™°√–∑àÕ¡. °√ÿ߇∑æœ:
                 Mitragyna speciosa Korth leaf extract on phase II drug  §≥–°√√¡°“√ªØ‘√Ÿª°ÆÀ¡“¬; 2558. Àπ—ß ◊Õ∑’Ë §ª°.(√)
                 metabolizing enzymes-glutathione transferases (GSTs).  3/2558.
                 Molecules. 2010;15(1):432-41.            49. Assanangkornchai S, Pattanasattayawong U, Samangsri
              37. Harizal SN, Mansor SM, Hasnan J, Thanakan JKJ, Abdullah  N, Mukthong A. Substance use among high-school
                 J. Acute toxicity study of the standard methanolic extract  students in southern Thailand: Trends over 3 years (2002-
                 of Mitragyna speciosa Korth in Rodent. J Ethnopharmacol.  2004). Drug Alcohol Depend. 2007;86(2-3):167-74.
                 2010;131(2):404-9.                       50. Assanangkornchai S, Aramrattana A, Perngparn U, Kanato
              38. Singh D, Muller CP, Vicknasingam BK, Mansor SM. Social  M, Kanika N, Sirivongs Na Ayudhya A. Current situation
                 functioning of Kratom (Mitragyna speciosa) users in  of substance-related problems in Thailand. J Psychiatr
                 Malaysia. J Psychoactive Drugs. 2015;47(2):125-31.  Assoc Thailand. 2008;53(Suppl 1):24S-36S.
              39. Singh D, Muller CP, Vicknasingam BK. Kratom (Mitragyna  51. Ingsathit A, Woratanarat P, Anukarahanonta T, Rattanasiri
                 speciosa) dependence, withdrawal symptoms and craving  S, Chatchaipun P, Wattayakorn K, et al. Prevalence of
                 in regular users. Drug Alcohol Depend. 2014;139:132-7.  psychoactive drug use among drivers in Thailand: a roadside
              40. Neerman MF, Frost RE, Deking J. A drug fatality involving  survey. Accid Anal Prev. 2009;41(3):474-8.
                 kratom. J Forensic Sci. 2013;58(Suppl 1):S278-9.  52. European Monitoring Centre for Drugs and Drug Addition.
              41. Holler JM, Vorce SP, McDonough-Bender PC, Maqluilo J  Kratom drug profile. [Internet]. 2015 [cited 2016 Nov 8].
                 Jr, Solomon CJ, Levine B. A drug toxicity death involving  Available from: www.emcdda.europa.eu/publications/drug-
                 propylhexedrine and mitragynine. J Anal Toxicol.  profiles/kratom
                 2011;35(1):54-9.                         53. United Nations Office on Drugs and Crime. World drug
              42. McIntyre IM, Trochta A, Stolberg S, Campman SC.  report 2014. [Internet]. 2014 [cited 2016 Nov 8]. Available
                 Mitragynine, ùKratomû related fatality: a case report with  from: http://www.unodc.org/documents/wdr2014/
                 post-mortem concentration. J Anal Toxicol. 2015;39(2):152-  World_Drug_Report_2014_web.pdf
                 5.                                       54. Prozialeck WC, Jivan JK, Andurkar SV. Pharmacology of
              43. Ramanathan S, Parthasarathy S, Murugaiyah V, Magosso  Kratom: an emerging botanical agent with stimulant,
   32   33   34   35   36   37   38   39   40   41   42